TSX Venture Exchange (TSXV) · KNE.V · ISIN CA4838092084
Kane Biotech Inc.
0.0300 CAD
0(0.00%)unchangedPrevious close · Sep 18, 09:30 ET
Data last updated: (1 d ago)· Delayed exchange data
Kane Biotech Inc. (KNE.V) trades on the TSX Venture Exchange and operates in the Biotechnology industry. Its market capitalisation is approximately 6.15M CAD. The company reports around 32 employees. Its ISIN is CA4838092084. This page shows the latest available price, the day and 52-week ranges and an interactive chart. Quotes are delayed and are not intended for order execution.
Checking today's session…
Key facts
Exchange
TSX Venture Exchange (TSXV)
ISIN
CA4838092084
Sector
Healthcare
Industry
Biotechnology
Country
CA
Market cap
6.15M CAD
Employees
32
Previous close
0.03 CAD
Day range
0.03 – 0.03
52-week range
0.02 – 0.05
Volume
5K
50-day average
0.03 CAD
200-day average
0.04 CAD
Asset type
Equity
About Kane Biotech Inc.
Headquartered in Winnipeg, Canada, Kane Biotech Inc. is a biotechnology firm established in 2001, focusing on the research, development, and global commercialization of innovative technologies and products engineered to prevent and remove microbial biofilms. The company's diverse portfolio features pet dental hygiene solutions marketed as StrixNB and bluestem, alongside DispersinB for both animal and human wound care. They also provide Alosera brand shampoos for dogs, cats, and horses, and Aledex for medical device coatings. Additional offerings include DermaKB scalp care products, Coactiv+ wound care items, and other specialized products under the goldstem, silkstem, and DermaKB Biofilm brand names.
Company websiteFrequently asked
- What is the KNE.V share price today?
- This page shows the latest available Kane Biotech Inc. (KNE.V) price with its change against the prior close. Values are delayed or previous-close, not real-time.
- Where is Kane Biotech Inc. listed?
- Kane Biotech Inc. trades on the TSX Venture Exchange under the symbol KNE.V, ISIN CA4838092084.
- How large is Kane Biotech Inc.?
- Its market capitalisation is approximately 6.15M CAD, based on the latest available price and share count from our data provider.
+
+
+
All Kane Biotech Inc. data comes from exchange and provider feeds for the TSX Venture Exchange and is published for information, not as investment advice.
Real-time quotes are not licensed; prices are delayed or previous close, so they may lag the market by 15 minutes or a full session. Information only, not for trading. Where a figure is not covered by our licensed sources, the page says so rather than showing a substitute.